Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors. 2007

Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
Center for Drug Discovery, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka 422-8526, Japan.

Inhibition of Eg5 represents a novel approach for the treatment of cancer. Here, we report the synthesis and structure-activity relationship of S-trityl-L-cysteine (STLC) derivatives as Eg5 inhibitors. Some of these derivatives such as 4f demonstrated enhanced inhibitory activity against Eg5 and induced mitotic arrest with characteristic monoastral spindles in HeLa cells.

UI MeSH Term Description Entries
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016547 Kinesins A family of microtubule-associated mechanical adenosine triphosphatases, that uses the energy of ATP hydrolysis to move organelles along microtubules including mitosis, meiosis, and axonal transport. Kinesin,Kinesin Heavy-Chain Protein,Kinesin Light-Chain Protein,Kinesin Light-Chain Proteins,Kinesin Superfamily,Heavy-Chain Protein, Kinesin,Light-Chain Protein, Kinesin,Light-Chain Proteins, Kinesin,Protein, Kinesin Heavy-Chain,Protein, Kinesin Light-Chain,Proteins, Kinesin Light-Chain,Superfamily, Kinesin

Related Publications

Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
November 2005, Bioorganic & medicinal chemistry,
Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
July 2005, Chembiochem : a European journal of chemical biology,
Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
March 2008, Journal of medicinal chemistry,
Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
March 2019, Bioorganic chemistry,
Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
February 2015, ACS chemical biology,
Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
April 2014, Journal of biochemistry,
Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
September 2018, Bioorganic & medicinal chemistry letters,
Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
November 2005, Chembiochem : a European journal of chemical biology,
Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
August 2014, Bioorganic & medicinal chemistry letters,
Naohisa Ogo, and Shinya Oishi, and Kenji Matsuno, and Jun-ichi Sawada, and Nobutaka Fujii, and Akira Asai
May 2011, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!